D-0115-2025 Class II Terminated

Recalled by LNK International, Inc. — Hauppauge, NY

FDA drug recall D-0115-2025 was initiated by LNK International, Inc. on Nov 14, 2024 and is designated Class II. Reason for recall: CGMP Deviations: Released product should have been rejected. The recall status is terminated (terminated Sep 2, 2025). Affected quantity: 288 cases x 30 8,640 boxes.

Recall Details

Product Type
Drugs
Report Date
Dec 18, 2024
Initiation Date
Nov 14, 2024
Termination Date
Sep 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
288 cases x 30 8,640 boxes

Product Description

Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg); Night - 56 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Doxylamine succinate 6.25 mg, Phenylephrine HCl 5 mg); Manufactured BY: LNK International, Inc. FOR: Costco Wholesale Corporation. NDC# 63981-795-81

Reason for Recall

CGMP Deviations: Released product should have been rejected.

Distribution Pattern

Product was distributed to 1 wholesale retail customer who may have further distribute the product nationwide.

Code Information

Lot # P139953, exp. date 2026/AUG Lot # P139815, exp. date 2026/AUG

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0115-2025
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0115-2025. Report a data issue: hello@regdatalab.com.